搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
7 小时
Inflation Reduction Act Unintended Consequences For Medical Innovation
IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...
STAT
11 小时
DeepSeek signals China’s rising influence in AI — and AI drug development
There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...
BioSpace
6 小时
The APAC Opportunity: Why Clinical Trials Are Shifting East
APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.
3 天
on MSN
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
pharmaphorum
3 天
Leading pharma companies unite to accelerate new drug development
This new organisation, called TransCelerate BioPharma Inc., will be the largest ever initiative of its kind. It will aim to identify and solve common drug development challenges, with the end ...
来自MSN
10 天
New AI software could speed up drug development
The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...
The University of Chicago Chronicle
5 天
Collaboration to provide up to $130 million to fuel drug discovery, development at UChicago
Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...
12 天
The Dangers Hidden In CMS’ Drug Pricing Regulation
The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...
10 天
AI Tool to Slash Pharma Development Costs by Predicting Drug Trial Outcomes
A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.
3 天
on MSN
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈